Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris
Condition: Acne Vulgaris Interventions: Drug: Clindamycin Phosphate; Drug: Clindamycin Phosphate RLD; Drug: Placebos Sponsor: Taro Pharmaceuticals USA Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials